{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:52:19Z","timestamp":1792860739907,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03371-0","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T23:10:44Z","timestamp":1772665844000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["DoE-based Development of Transdermal Risedronate-laden Cubosomes: In Vitro Characterization, Drug Deposition, and In Vivo Permeation in Rats"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8769-4049","authenticated-orcid":false,"given":"Amrendra J.","family":"Gautam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0124-1741","authenticated-orcid":false,"given":"Sarika","family":"Wairkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"3371_CR1","doi-asserted-by":"publisher","unstructured":"Ali MS, Abdullah Almoyad MA, Wahab S, Sahebkar A, Gorain B, Kaur H, et al. Recent advances in lipid-based nanocarriers for advanced skin cancer therapy. Int J Pharm. 2025. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125203.","DOI":"10.1016\/j.ijpharm.2025.125203"},{"key":"3371_CR2","doi-asserted-by":"publisher","unstructured":"Rachmawati P, Susanto S, Christian YE. Impact of sterilization method on the system performance of lipid-based novel drug delivery. Int J Pharm. 2025. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125486.","DOI":"10.1016\/j.ijpharm.2025.125486"},{"key":"3371_CR3","doi-asserted-by":"publisher","unstructured":"Srivastav AK, Karpathak S, Rai MK, Kumar D, Misra DP, Agarwal V. Lipid based drug delivery systems for oral, transdermal and parenteral delivery: recent strategies for targeted delivery consistent with different clinical application. J Drug Deliv Sci Technol. 2023. https:\/\/doi.org\/10.1016\/j.jddst.2023.104526.","DOI":"10.1016\/j.jddst.2023.104526"},{"key":"3371_CR4","doi-asserted-by":"publisher","unstructured":"Gunawan M, Bestari AN, Ramadon D, Efendi A, Boonkanokwong V. Combination of lipid-based nanoparticles with microneedles as a promising strategy for enhanced transdermal delivery systems: a comprehensive review. J Drug Deliv Sci Technol. 2025. https:\/\/doi.org\/10.1016\/j.jddst.2025.106807.","DOI":"10.1016\/j.jddst.2025.106807"},{"key":"3371_CR5","doi-asserted-by":"publisher","unstructured":"Patel D, Wairkar S. Hyaluronate-incorporated edaravone nanostructured lipid carriers for nose-to-brain targeting- biphasic DoE optimization, pharmacokinetic, and brain distribution studies. Int J Biol Macromol.2025;310. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.143236.","DOI":"10.1016\/j.ijbiomac.2025.143236"},{"key":"3371_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.22270\/jddt.v10i1.3814","volume":"10","author":"A Dhadwal","year":"2020","unstructured":"Dhadwal A, Sharma DR, Pandit V, Ashawat MS, Kumar P. Cubosomes: a novel carrier for transdermal drug delivery. J Drug Deliv Ther. 2020;10:123\u201330. https:\/\/doi.org\/10.22270\/jddt.v10i1.3814.","journal-title":"J Drug Deliv Ther"},{"key":"3371_CR7","doi-asserted-by":"publisher","unstructured":"Umar H, Wahab HA, Gazzali AM, Tahir H, Ahmad W. Cubosomes: design, development, and tumor-targeted drug delivery applications. Polymers (Basel). 2022. https:\/\/doi.org\/10.3390\/polym14153118.","DOI":"10.3390\/polym14153118"},{"key":"3371_CR8","doi-asserted-by":"publisher","unstructured":"Sivadasan D, Sultan MH, Alqahtani SS, Javed S. Cubosomes in drug delivery\u2014a comprehensive review on its structural components, preparation techniques and therapeutic applications. Biomedicines. 2023. https:\/\/doi.org\/10.3390\/biomedicines11041114.","DOI":"10.3390\/biomedicines11041114"},{"key":"3371_CR9","doi-asserted-by":"publisher","unstructured":"Zhai J, Fong C, Tran N, Drummond CJ. Non-lamellar lyotropic liquid crystalline lipid nanoparticles for the next generation of nanomedicine. ACS Nano. 2019;6178\u2013206. https:\/\/doi.org\/10.1021\/acsnano.8b07961.","DOI":"10.1021\/acsnano.8b07961"},{"key":"3371_CR10","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.2147\/IJN.S61181","volume":"9","author":"IW Jung","year":"2014","unstructured":"Jung IW, Han HK. Effective mucoadhesive liposomal delivery system for risedronate: preparation and in vitro\/in vivo characterization. Int J Nanomedicine. 2014;9:2299\u2013306. https:\/\/doi.org\/10.2147\/IJN.S61181.","journal-title":"Int J Nanomedicine"},{"key":"3371_CR11","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ijpharm.2019.04.069","volume":"564","author":"YSR Elnaggar","year":"2019","unstructured":"Elnaggar YSR, Omran S, Hazzah HA, Abdallah OY. Anionic versus cationic bilosomes as oral nanocarriers for enhanced delivery of the hydrophilic drug risedronate. Int J Pharm. 2019;564:410\u201325. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.04.069.","journal-title":"Int J Pharm"},{"key":"3371_CR12","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1080\/02652048.2019.1631401","volume":"36","author":"S Santhosh","year":"2019","unstructured":"Santhosh S, Mukherjee D, Anbu J, Murahari M, Teja BV. Improved treatment efficacy of risedronate functionalized chitosan nanoparticles in osteoporosis: formulation development, in vivo, and molecular modelling studies. J Microencapsul. 2019;36:338\u201355. https:\/\/doi.org\/10.1080\/02652048.2019.1631401.","journal-title":"J Microencapsul"},{"key":"3371_CR13","doi-asserted-by":"publisher","unstructured":"Gyanewali S, Kesharwani P, Sheikh A, Ahmad FJ, Trivedi R, Talegaonkar S. Formulation development and in vitro\u2013in vivo assessment of protransfersomal gel of anti-resorptive drug in osteoporosis treatment. Int J Pharm. 2021;608. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.121060.","DOI":"10.1016\/j.ijpharm.2021.121060"},{"key":"3371_CR14","doi-asserted-by":"publisher","unstructured":"Wang C, Liu W, Huang Y, Zheng L, Wang L, Li R, et al. Mitigating gastrointestinal side effects of risedronate sodium: a study on Bletilla striata polysaccharide microneedle patches. Int J Pharm. 2025;677. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125609.","DOI":"10.1016\/j.ijpharm.2025.125609"},{"key":"3371_CR15","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1021\/acsomega.9b03464","volume":"5","author":"DK Khajuria","year":"2020","unstructured":"Khajuria DK, Vasireddi R, Priydarshi MK, Mahapatra DR. Ionic diffusion and drug release behavior of core-shell-functionalized alginate-chitosan-based hydrogel. ACS Omega. 2020;5:758\u201365. https:\/\/doi.org\/10.1021\/acsomega.9b03464.","journal-title":"ACS Omega"},{"key":"3371_CR16","doi-asserted-by":"publisher","unstructured":"Vaseem RS, D\u2019Cruz A, Shetty S, Hafsa, Vardhan A, Shenoy SR, et al. Transdermal drug delivery systems: a focused review of the physical methods of permeation enhancement. Adv Pharm Bull. 2024;67\u201385.  https:\/\/doi.org\/10.34172\/apb.2024.018.","DOI":"10.34172\/apb.2024.018"},{"key":"3371_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jcis.2023.11.059","volume":"656","author":"SL Yap","year":"2024","unstructured":"Yap SL, Yu H, Li S, Drummond CJ, Conn CE, Tran N. Cell interactions with lipid nanoparticles possessing different internal nanostructures: liposomes, bicontinuous cubosomes, hexosomes, and discontinuous micellar cubosomes. J Colloid Interface Sci. 2024;656:409\u201323. https:\/\/doi.org\/10.1016\/j.jcis.2023.11.059.","journal-title":"J Colloid Interface Sci"},{"key":"3371_CR18","doi-asserted-by":"publisher","unstructured":"Gautam AJ, Wairkar S. Transdermal delivery of risedronate via spanlastics for osteoporosis: formulation optimization, skin deposition, and pharmacokinetic assessment. Naunyn Schmiedebergs Arch Pharmacol. 2025. https:\/\/doi.org\/10.1007\/S00210-025-04786-5.","DOI":"10.1007\/S00210-025-04786-5"},{"key":"3371_CR19","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1007\/s13204-019-00976-9","volume":"9","author":"K Janakiraman","year":"2019","unstructured":"Janakiraman K, Krishnaswami V, Sethuraman V, Rajendran V, Kandasamy R. Development of methotrexate-loaded cubosomes with improved skin permeation for the topical treatment of rheumatoid arthritis. Appl Nanosci. 2019;9:1781\u201396. https:\/\/doi.org\/10.1007\/s13204-019-00976-9.","journal-title":"Appl Nanosci"},{"key":"3371_CR20","doi-asserted-by":"publisher","unstructured":"Liu G, Yang Y, Wu Q, Chen Z, Hamdy NM, Amin A, et al. Recent advances in biomedical applications of lyotropic liquid crystals. Acta Pharm Sin B. 2025. https:\/\/doi.org\/10.1016\/J.APSB.2025.12.008.","DOI":"10.1016\/J.APSB.2025.12.008"},{"key":"3371_CR21","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/J.1468-2494.2012.00749.X","volume":"34","author":"G Pennick","year":"2012","unstructured":"Pennick G, Chavan B, Summers B, Rawlings AV. The effect of an amphiphilic self-assembled lipid lamellar phase on the relief of dry skin. Int J Cosmet Sci. 2012;34:567\u201374. https:\/\/doi.org\/10.1111\/J.1468-2494.2012.00749.X.","journal-title":"Int J Cosmet Sci"},{"key":"3371_CR22","doi-asserted-by":"publisher","unstructured":"Nath AG, Dubey P, Kumar A, Vaiphei KK, Rosenholm JM, Bansal KK, et al. Recent advances in the use of cubosomes as drug carriers with special emphasis on topical applications. J Lipids. 2024:2683466. https:\/\/doi.org\/10.1155\/2024\/2683466.","DOI":"10.1155\/2024\/2683466"},{"key":"3371_CR23","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jddst.2019.04.036","volume":"52","author":"AE Eldeeb","year":"2019","unstructured":"Eldeeb AE, Salah S, Ghorab M. Formulation and evaluation of cubosomes drug delivery system for treatment of glaucoma: ex-vivo permeation and in-vivo pharmacodynamic study. J Drug Deliv Sci Technol. 2019;52:236\u201347. https:\/\/doi.org\/10.1016\/j.jddst.2019.04.036.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3371_CR24","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.ijpharm.2018.10.057","volume":"553","author":"NF Younes","year":"2018","unstructured":"Younes NF, Abdel-Halim SA, Elassasy AI. Corneal targeted Sertaconazole nitrate loaded cubosomes: preparation, statistical optimization, in vitro characterization, ex vivo permeation and in vivo studies. Int J Pharm. 2018;553:386\u201397. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.10.057.","journal-title":"Int J Pharm"},{"key":"3371_CR25","doi-asserted-by":"publisher","unstructured":"Badiger P, Mannur VS, Koli R. Dual drug-loaded cubosome nanoparticles for hepatocellular carcinoma: a design of experiment approach for optimization and in vitro evaluation. Futur J Pharm Sci. 2024;10.  https:\/\/doi.org\/10.1186\/s43094-024-00607-3.","DOI":"10.1186\/s43094-024-00607-3"},{"key":"3371_CR26","doi-asserted-by":"publisher","unstructured":"Karami Z, Hamidi M. Cubosomes: remarkable drug delivery potential. Drug Discov Today. 2016;789\u2013801. https:\/\/doi.org\/10.1016\/j.drudis.2016.01.004.","DOI":"10.1016\/j.drudis.2016.01.004"},{"key":"3371_CR27","doi-asserted-by":"publisher","unstructured":"Sultan AA, Nashar NFE, Ashmawy SM, Maghraby GME, Dove. Cubosomes for enhancing intestinal absorption of fexofenadine hydrochloride, In: Situ and In Vivo investigation. Int J Nanomed. 2022;17:3543\u201360. https:\/\/doi.org\/10.2147\/IJN.S370235.","DOI":"10.2147\/IJN.S370235"},{"key":"3371_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jddst.2018.09.002","volume":"48","author":"R Nithya","year":"2018","unstructured":"Nithya R, Jerold P, Siram K. Cubosomes of dapsone enhanced permeation across the skin. J Drug Deliv Sci Technol. 2018;48:75\u201381. https:\/\/doi.org\/10.1016\/j.jddst.2018.09.002.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3371_CR29","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ijpharm.2015.05.064","volume":"490","author":"FE Abdelrahman","year":"2015","unstructured":"Abdelrahman FE, Elsayed I, Gad MK, Badr A, Mohamed MI. Investigating the cubosomal ability for transnasal brain targeting: in vitro optimization, ex vivo permeation and in vivo biodistribution. Int J Pharm. 2015;490:281\u201391. https:\/\/doi.org\/10.1016\/j.ijpharm.2015.05.064.","journal-title":"Int J Pharm"},{"key":"3371_CR30","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1016\/j.xphs.2021.02.007","volume":"110","author":"AM Mohsen","year":"2021","unstructured":"Mohsen AM, Younis MM, Salama A, Darwish AB. Cubosomes as a potential oral drug delivery system for enhancing the hepatoprotective effect of Coenzyme Q10. J Pharm Sci. 2021;110:2677\u201386. https:\/\/doi.org\/10.1016\/j.xphs.2021.02.007.","journal-title":"J Pharm Sci"},{"key":"3371_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.apsb.2014.12.001","volume":"5","author":"M Nasr","year":"2015","unstructured":"Nasr M, Ghorab MK, Abdelazem A. In vitro and in vivo evaluation of cubosomes containing 5-fluorouracil for liver targeting. Acta Pharm Sin B. 2015;5:79\u201388. https:\/\/doi.org\/10.1016\/j.apsb.2014.12.001.","journal-title":"Acta Pharm Sin B"},{"key":"3371_CR32","doi-asserted-by":"publisher","unstructured":"Patil MV, Mhaldar PM, Tayade SN, Rashinkar GS, Pore DM. Surfactant based nanoreactor micellar assembly: an innovative route for synthesis of 2-thioxo-2,3-dihydroquinazolin-4(1H)-ones. J Mol Liq. 2022;359. https:\/\/doi.org\/10.1016\/j.molliq.2022.119305.","DOI":"10.1016\/j.molliq.2022.119305"},{"key":"3371_CR33","doi-asserted-by":"publisher","first-page":"62119","DOI":"10.1039\/c6ra09616f","volume":"6","author":"V Miceli","year":"2016","unstructured":"Miceli V, Meli V, Blanchard-Desce M, Bsaibess T, Pampalone M, Conaldi PG, et al. In vitro imaging of \u03b2-cells using fluorescent cubic bicontinuous liquid crystalline nanoparticles. RSC Adv. 2016;6:62119\u201327. https:\/\/doi.org\/10.1039\/c6ra09616f.","journal-title":"RSC Adv"},{"key":"3371_CR34","doi-asserted-by":"publisher","first-page":"9566","DOI":"10.1021\/acs.langmuir.5b02101","volume":"31","author":"V Meli","year":"2015","unstructured":"Meli V, Caltagirone C, Falchi AM, Hyde ST, Lippolis V, Monduzzi M, et al. Docetaxel-loaded fluorescent liquid-crystalline nanoparticles for cancer theranostics. Langmuir. 2015;31:9566\u201375. https:\/\/doi.org\/10.1021\/acs.langmuir.5b02101.","journal-title":"Langmuir"},{"key":"3371_CR35","doi-asserted-by":"publisher","unstructured":"Rapalli VK, Banerjee S, Khan S, Jha PN, Gupta G, Dua K, et al. QbD-driven formulation development and evaluation of topical hydrogel containing ketoconazole loaded cubosomes. Mater Sci Eng C Mater Biol. 2021;119. https:\/\/doi.org\/10.1016\/j.msec.2020.111548.","DOI":"10.1016\/j.msec.2020.111548"},{"key":"3371_CR36","doi-asserted-by":"publisher","unstructured":"Mansour M, Abo El Ezz TA, Fattoh FN, AbouelFadl DM, Gad HA. Delineating the usage of dexamethasone-loaded cubosomes as a therapeutic armamentarium for hearing loss versus its protective effect: in-vitro and in-vivo animal study. J Drug Deliv Sci Technol. 2021. https:\/\/doi.org\/10.1016\/j.jddst.2020.102244.","DOI":"10.1016\/j.jddst.2020.102244"},{"key":"3371_CR37","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ejpb.2013.04.018","volume":"86","author":"NM Morsi","year":"2014","unstructured":"Morsi NM, Abdelbary GA, Ahmed MA. Silver sulfadiazine based cubosome hydrogels for topical treatment of burns: development and in vitro\/in vivo characterization. Eur J Pharm Biopharm. 2014;86:178\u201389. https:\/\/doi.org\/10.1016\/j.ejpb.2013.04.018.","journal-title":"Eur J Pharm Biopharm"},{"key":"3371_CR38","doi-asserted-by":"publisher","unstructured":"Khan BA, Ahmad N, Alqahtani A, Baloch R, Rehman AU, Khan MK. Formulation development of pharmaceutical nanoemulgel for transdermal delivery of feboxostat: physical characterization and in vivo evaluation. Eur J Pharm Sci. 2024;195. https:\/\/doi.org\/10.1016\/j.ejps.2023.106665.","DOI":"10.1016\/j.ejps.2023.106665"},{"key":"3371_CR39","doi-asserted-by":"publisher","first-page":"12037","DOI":"10.33263\/BRIAC114.1203712054","volume":"11","author":"AK Chettupalli","year":"2021","unstructured":"Chettupalli AK, Ananthula M, Amarachinta PR, Bakshi V, Yata VK. Design, formulation, in-vitro and ex-vivo evaluation of atazanavir loaded cubosomal gel. Biointerface Res Appl Chem. 2021;11:12037\u201354. https:\/\/doi.org\/10.33263\/BRIAC114.1203712054.","journal-title":"Biointerface Res Appl Chem"},{"key":"3371_CR40","doi-asserted-by":"publisher","unstructured":"Sanjana A, Ahmed MG, Gowda JBH. Development and evaluation of dexamethasone loaded cubosomes for the treatment of vitiligo. Mater Today Proc. 2021;197\u2013205. https:\/\/doi.org\/10.1016\/j.matpr.2021.04.120.","DOI":"10.1016\/j.matpr.2021.04.120"},{"key":"3371_CR41","doi-asserted-by":"publisher","unstructured":"Diaa Abdullah H, Kamal I, Sabry SA, Abd elghany M, El hakim Ramadan A. Clarithromycin-tailored cubosome: a sustained release oral nano platform for evaluating antibacterial, anti-biofilm, anti-inflammatory, anti-liver cancer, biocompatibility, ex-vivo and in-vivo studies. Int J Pharm. 2024;667. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124865.","DOI":"10.1016\/j.ijpharm.2024.124865"},{"key":"3371_CR42","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.ijbiomac.2020.07.168","volume":"164","author":"RL Nagula","year":"2020","unstructured":"Nagula RL, Wairkar S. Cellulose microsponges based gel of naringenin for atopic dermatitis: design, optimization, in vitro and in vivo investigation. Int J Biol Macromol. 2020;164:717\u201325. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.07.168.","journal-title":"Int J Biol Macromol"},{"key":"3371_CR43","doi-asserted-by":"publisher","unstructured":"Rapalli VK, Singhvi G. Dermato-pharmacokinetic: assessment tools for topically applied dosage forms. Expert Opin Drug Deliv. 2021;423\u20136. https:\/\/doi.org\/10.1080\/17425247.2021.1856071.","DOI":"10.1080\/17425247.2021.1856071"},{"key":"3371_CR44","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ijpharm.2016.05.005","volume":"507","author":"MI Siddique","year":"2016","unstructured":"Siddique MI, Katas H, Amin MCIM, Ng SF, Zulfakar MH, Jamil A. In-vivo dermal pharmacokinetics, efficacy, and safety of skin targeting nanoparticles for corticosteroid treatment of atopic dermatitis. Int J Pharm. 2016;507:72\u201382. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.05.005.","journal-title":"Int J Pharm"},{"key":"3371_CR45","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.aca.2006.01.077","volume":"562","author":"HJ Jia","year":"2006","unstructured":"Jia HJ, Li W, Zhao K. Determination of risedronate in rat plasma samples by ion-pair high-performance liquid chromatography with UV detector. Anal Chim Acta. 2006;562:171\u20135. https:\/\/doi.org\/10.1016\/j.aca.2006.01.077.","journal-title":"Anal Chim Acta"},{"key":"3371_CR46","unstructured":"British Pharmacopoeia Commission. British pharmacopoeia 2022, Vol. 2. London: The Stationery Office; 2021. p. 828\u20139."},{"key":"3371_CR47","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1080\/02678292.2020.1836276","volume":"48","author":"T Waghule","year":"2021","unstructured":"Waghule T, Patil S, Rapalli VK, Girdhar V, Gorantla S, Kumar Dubey S, et al. Improved skin-permeated diclofenac-loaded lyotropic liquid crystal nanoparticles: QbD-driven industrial feasible process and assessment of skin deposition. Liq Cryst. 2021;48:991\u20131009. https:\/\/doi.org\/10.1080\/02678292.2020.1836276.","journal-title":"Liq Cryst"},{"key":"3371_CR48","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jchromb.2011.11.031","volume":"881","author":"S Ghassabian","year":"2012","unstructured":"Ghassabian S, Wright LA, deJager AD, Smith MT. Development and validation of a sensitive solid-phase-extraction (SPE) method using high-performance liquid chromatography\/tandem mass spectrometry (LC-MS\/MS) for determination of risedronate concentrations in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2012;881:34\u201341. https:\/\/doi.org\/10.1016\/j.jchromb.2011.11.031.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"3371_CR49","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1002\/jps.23136","volume":"101","author":"H Katsumi","year":"2012","unstructured":"Katsumi H, Liu S, Tanaka Y, Hitomi K, Hayashi R, Hirai Y, et al. Development of a novel self-dissolving microneedle array of alendronate, a nitrogen-containing bisphosphonate: evaluation of transdermal absorption, safety, and pharmacological effects after application in rats. J Pharm Sci. 2012;101:3230\u20138. https:\/\/doi.org\/10.1002\/jps.23136.","journal-title":"J Pharm Sci"},{"key":"3371_CR50","unstructured":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use ich harmonised tripartite guideline stability testing of new drug substances and products Q1A(R2). 2003."},{"key":"3371_CR51","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1208\/s12249-009-9293-3","volume":"10","author":"D Bei","year":"2009","unstructured":"Bei D, Marszalek J, Youan BBC. Formulation of dacarbazine-loaded cubosomes-part I: influence of formulation variables. AAPS PharmSciTech. 2009;10:1032\u20139. https:\/\/doi.org\/10.1208\/s12249-009-9293-3.","journal-title":"AAPS PharmSciTech"},{"key":"3371_CR52","doi-asserted-by":"publisher","unstructured":"Rizwan SB, Boyd BJ. Cubosomes: Structure, preparation and use as an antigen delivery system. 2015;125\u201340.  https:\/\/doi.org\/10.1007\/978-1-4939-1417-3_7.","DOI":"10.1007\/978-1-4939-1417-3_7"},{"key":"3371_CR53","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ejpb.2016.05.001","volume":"104","author":"H Azhari","year":"2016","unstructured":"Azhari H, Strauss M, Hook S, Boyd BJ, Rizwan SB. Stabilising cubosomes with Tween 80 as a step towards targeting lipid nanocarriers to the blood-brain barrier. Eur J Pharm Biopharm. 2016;104:148\u201355. https:\/\/doi.org\/10.1016\/j.ejpb.2016.05.001.","journal-title":"Eur J Pharm Biopharm"},{"key":"3371_CR54","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/aps.2010.98","volume":"31","author":"S Han","year":"2010","unstructured":"Han S, Shen JQ, Gan Y, Geng HM, Zhang XX, Zhu CL, et al. Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability. Acta Pharmacol Sin. 2010;31:990\u20138. https:\/\/doi.org\/10.1038\/aps.2010.98.","journal-title":"Acta Pharmacol Sin"},{"key":"3371_CR55","doi-asserted-by":"publisher","first-page":"9907","DOI":"10.1021\/acs.langmuir.7b02486","volume":"33","author":"CV Kulkarni","year":"2017","unstructured":"Kulkarni CV, Vishwapathi VK, Quarshie A, Moinuddin Z, Page J, Kendrekar P, et al. Self-assembled lipid cubic phase and cubosomes for the delivery of aspirin as a model drug. Langmuir. 2017;33:9907\u201315. https:\/\/doi.org\/10.1021\/acs.langmuir.7b02486.","journal-title":"Langmuir"},{"key":"3371_CR56","doi-asserted-by":"publisher","unstructured":"Rapalli VK, Sharma S, Roy A, Singhvi G. Design and dermatokinetic evaluation of Apremilast loaded nanostructured lipid carriers embedded gel for topical delivery: A potential approach for improved permeation and prolong skin deposition. Coll Surf B Biointerfaces. 2021;206. https:\/\/doi.org\/10.1016\/j.colsurfb.2021.111945.","DOI":"10.1016\/j.colsurfb.2021.111945"},{"key":"3371_CR57","doi-asserted-by":"publisher","unstructured":"Gowda CM, Wairkar S. Azelaic acid-based lyotropic liquid crystals gel for acne vulgaris: formulation optimization, antimicrobial activity and dermatopharmacokinetic study. Int J Pharm. 2024;667. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124879.","DOI":"10.1016\/j.ijpharm.2024.124879"},{"key":"3371_CR58","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1177\/00912700022008928","volume":"40","author":"DY Mitchell","year":"2000","unstructured":"Mitchell DY, Eusebio RA, Sacco-Gibson NA, Pallone KA, Kelly SC, Nesbitt JD, et al. Dose-Proportional Pharmacokinetics of Risedronate on Single-Dose Oral Administration to Healthy Volunteers. J Clin Pharmacol. 2000;40:258\u201365. https:\/\/doi.org\/10.1177\/00912700022008928.","journal-title":"J Clin Pharmacol"},{"key":"3371_CR59","doi-asserted-by":"publisher","unstructured":"Saifi Z, Ralli T, Rizwanullah Md, Alam M, Vohora D, Mir SR, et al. BBD driven fabrication of hydroxyapatite engineered risedronate loaded thiolated chitosan nanoparticles and their in silico, in vitro, and ex vivo studies. Micromachines (Basel). 2023;14:2182. https:\/\/doi.org\/10.3390\/mi14122182.","DOI":"10.3390\/mi14122182"},{"key":"3371_CR60","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ijpharm.2016.04.049","volume":"506","author":"P Rawat","year":"2016","unstructured":"Rawat P, Ahmad I, Thomas SC, Pandey S, Vohora D, Gupta S, et al. Revisiting bone targeting potential of novel hydroxyapatite based surface modified PLGA nanoparticles of risedronate: pharmacokinetic and biochemical assessment. Int J Pharm. 2016;506:253\u201361. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.04.049.","journal-title":"Int J Pharm"},{"key":"3371_CR61","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.1021\/la010161w","volume":"17","author":"PT Spicer","year":"2001","unstructured":"Spicer PT, Hayden KL, Lynch ML, Ofori-Boateng A, Burns JL. Novel process for producing cubic liquid crystalline nanoparticles (cubosomes). Langmuir. 2001;17:5748\u201356. https:\/\/doi.org\/10.1021\/la010161w.","journal-title":"Langmuir"},{"key":"3371_CR62","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ijpharm.2005.11.033","volume":"309","author":"BJ Boyd","year":"2006","unstructured":"Boyd BJ, Whittaker DV, Khoo SM, Davey G. Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems. Int J Pharm. 2006;309:218\u201326. https:\/\/doi.org\/10.1016\/j.ijpharm.2005.11.033.","journal-title":"Int J Pharm"},{"key":"3371_CR63","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jsps.2017.12.007","volume":"26","author":"AA Matloub","year":"2018","unstructured":"Matloub AA, AbouSamra MM, Salama AH, Rizk MZ, Aly HF, Fouad GI. Cubic liquid crystalline nanoparticles containing a polysaccharide from Ulva fasciata with potent antihyperlipidaemic activity. Saudi Pharm J. 2018;26:224\u201331. https:\/\/doi.org\/10.1016\/j.jsps.2017.12.007.","journal-title":"Saudi Pharm J"},{"key":"3371_CR64","doi-asserted-by":"publisher","unstructured":"Faisal MM, Gomaa E, Ibrahim AE, El Deeb S, Al-Harrasi A, Ibrahim TM. Verapamil-loaded cubosomes for enhancing intranasal drug delivery: development, characterization, ex vivo permeation, and brain biodistribution studies. AAPS PharmSciTech. 2024;25. https:\/\/doi.org\/10.1208\/s12249-024-02814-w.","DOI":"10.1208\/s12249-024-02814-w"},{"key":"3371_CR65","doi-asserted-by":"publisher","first-page":"32008","DOI":"10.1039\/d4ra04816d","volume":"14","author":"M Nawaz","year":"2024","unstructured":"Nawaz M, Hayat S, Farooq U, Iqbal MA, Khalid SH, Nee TW, et al. Development of N-alkylated benzimidazole based cubosome hydrogel for topical treatment of burns. RSC Adv. 2024;14:32008\u201320. https:\/\/doi.org\/10.1039\/d4ra04816d.","journal-title":"RSC Adv"},{"key":"3371_CR66","doi-asserted-by":"publisher","first-page":"5971","DOI":"10.2147\/IJN.S119286","volume":"11","author":"Y Zheng","year":"2016","unstructured":"Zheng Y, Ouyang WQ, Wei YP, Syed SF, Hao CS, Wang BZ, et al. Effects of Carbopol\u00ae 934 proportion on nanoemulsion gel for topical and transdermal drug delivery: a skin permeation study. Int J Nanomedicine. 2016;11:5971\u201387. https:\/\/doi.org\/10.2147\/IJN.S119286.","journal-title":"Int J Nanomedicine"},{"key":"3371_CR67","doi-asserted-by":"publisher","unstructured":"Rapalli VK, Tomar Y, Sharma S, Roy A, Singhvi G. Apremilast loaded lyotropic liquid crystalline nanoparticles embedded hydrogel for improved permeation and skin retention: an effective approach for psoriasis treatment. Biomed Pharmacother. 2023;162. https:\/\/doi.org\/10.1016\/j.biopha.2023.114634.","DOI":"10.1016\/j.biopha.2023.114634"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03371-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03371-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03371-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:52:02Z","timestamp":1780390322000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03371-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":67,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["3371"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03371-0","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There have been no reported conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"130"}}